A drug discovery case history of ‘‘delta-9-tetrahydrocannabinol, cannabidiol’’

Author： Tanasescu Radu Rog David Constantinescu Cris S

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.4, 2011-04, pp. : 437-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine

By Robson Philip

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 675-685

Informa Healthcare

Access to resources Recommend Favorite

Effect of low doses of ∆⁹-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats

By Parker Linda Burton Page Sorge Robert Yakiwchuk Christine Mechoulam Raphael

Psychopharmacology, Vol. 175, Iss. 3, 2004-09 ,pp. : 360-366

Springer Publishing Company

Access to resources Recommend Favorite

Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4966-4979

Bentham Science Publishers

Access to resources Recommend Favorite

The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5113-5130

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Protein after Delta-9-tetrahydrocannabinol in a Human Neuroblastoma Cell Line

By Lew G.M.

General Pharmacology, Vol. 27, Iss. 7, 1996-10 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite